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Hepatitis C virus (HCV) co-infection in HIV positive
patients can affect the pharmacokinetics (PK) of antiretro-
viral drugs that are metabolized by the liver. Therefore, we
determined plasma nevirapine (NVP) concentrations
(Ctrough) in HIV+ patients with or without HCV co-
infection.
This was a prospective study in patients receiving
NVP (200 mg twice daily or 400 mg once daily) for at
least 12 weeks as a part of antiretroviral regimen, at the
HIV/AIDS Centre, Infective and Tropical Disease Clinic,
Belgrade, Serbia. Written consent was obtained and the
study was approved by the local ethics committee.
NVP plasma concentrations were measured by a vali-
dated HPLC-UV method at the University of Liverpool,
UK. Statistical analysis was performed by SPSS software
package.
27 patients (18 HIV mono-infected and 9 HCV/HIV
co-infected patients) receiving NVP as part of their anti-
retroviral therapy were enrolled. The median age of the
27 patients was 43 years and all were Caucasian. In all
patients HIV RNA was <50 copies/mL; median CD4+
T-cells count was 363 cells/cmm. Median NVP Ctrough
was 4826 ng/mL (2533-8718 ng/mL) in the HIV mono-
infected group and 5810 ng/mL (4998-11783 ng/mL) in
the HIV/HCV co-infected group, respectively. Compared
to an individual with HIV mono-infection, those with
HCV/HIV co-infection had a higher NVP trough level
(95%CI +67 ng/mL, +2940 ng/mL; P=0.03). NVP plasma
levels above the toxic threshold (8000 ng/mL) were
more frequent in patients with liver cirrhosis than in
those without (33% vs. 4%; P <0.001).
Despite the small numbers of patients included, this PK
study has shown that NVP plasma levels are impaired in
HIV-infected patients co-infected with HCV, especially in
those with liver fibrosis.
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